loadpatents
Patent applications and USPTO patent grants for Molineaux; Christopher J..The latest application filed is for "enhanced erythropoiesis and iron metabolism".
Patent | Date |
---|---|
Enhanced Erythropoiesis And Iron Metabolism App 20210114987 - Klaus; Stephen J. ;   et al. | 2021-04-22 |
Enhanced erythropoiesis and iron metabolism Grant 10,894,774 - Klaus , et al. January 19, 2 | 2021-01-19 |
Enhanced erythropoiesis and iron metabolism Grant 10,882,827 - Klaus , et al. January 5, 2 | 2021-01-05 |
Enhanced erythropoiesis and iron metabolism Grant 10,626,090 - Klaus , et al. | 2020-04-21 |
Enhanced Erythropoiesis And Iron Metabolism App 20180208558 - Klaus; Stephen J. ;   et al. | 2018-07-26 |
Enhanced Erythropoiesis And Iron Metabolism App 20180162819 - Klaus; Stephen J. ;   et al. | 2018-06-14 |
Enhanced erythropoiesis and iron metabolism Grant 9,920,011 - Klaus , et al. March 20, 2 | 2018-03-20 |
Enhanced Erythropoiesis and Iron Metabolism App 20170267641 - Klaus; Stephen J. ;   et al. | 2017-09-21 |
Enhanced Erythropoiesis and Iron Metabolism App 20170224673 - Klaus; Stephen J. ;   et al. | 2017-08-10 |
Enhanced Erythropoiesis and Iron Metabolism App 20170216274 - Klaus; Stephen J. ;   et al. | 2017-08-03 |
Enhanced Erythropoiesis and Iron Metabolism App 20170216248 - Klaus; Stephen J. ;   et al. | 2017-08-03 |
Enhanced Erythropoiesis and Iron Metabolism App 20150246886 - Klaus; Stephen J. ;   et al. | 2015-09-03 |
Enhanced Erythropoiesis and Iron Metabolism App 20140142136 - Klaus; Stephen J. ;   et al. | 2014-05-22 |
Enhanced erythropoiesis and iron metabolism Grant 8,629,131 - Klaus , et al. January 14, 2 | 2014-01-14 |
Enhanced erythropoiesis and iron metabolism Grant 8,614,204 - Klaus , et al. December 24, 2 | 2013-12-24 |
Enhanced erythropoiesis and iron metabolism Grant 8,609,646 - Klaus , et al. December 17, 2 | 2013-12-17 |
Enhanced erythropoiesis and iron metabolism Grant 8,604,013 - Klaus , et al. December 10, 2 | 2013-12-10 |
Enhanced erythropoiesis and iron metabolism Grant 8,604,012 - Klaus , et al. December 10, 2 | 2013-12-10 |
Enhanced erythropoiesis and iron metabolism App 20110039886 - Klaus; Stephen J. ;   et al. | 2011-02-17 |
Enhanced erythropoiesis and iron metabolism App 20110038950 - Klaus; Stephen J. ;   et al. | 2011-02-17 |
Enhanced erythropoiesis and iron metabolism App 20100280044 - Klaus; Stephen J. ;   et al. | 2010-11-04 |
Enhanced erythropoiesis and iron metabolism App 20100278941 - Klaus; Stephen J. ;   et al. | 2010-11-04 |
Methods for treating FSH related conditions with GnRH antagonists App 20090197813 - Garnick; Marc B. ;   et al. | 2009-08-06 |
Pharmaceutical formulations for sustained drug delivery App 20070185032 - Gefter; Malcolm L. ;   et al. | 2007-08-09 |
Pharmaceutical formulations for sustained drug delivery App 20070185033 - Gefter; Malcolm L. ;   et al. | 2007-08-09 |
Methods for treating FSH related conditions with GnRH antagonists App 20070015714 - Garnick; Marc B. ;   et al. | 2007-01-18 |
Methods for treating FSH related conditions with GnRH antagonists Grant 7,109,171 - Garnick , et al. September 19, 2 | 2006-09-19 |
Enhanced erythropoiesis and iron metabolism App 20050020487 - Klaus, Stephen J. ;   et al. | 2005-01-27 |
Pharmaceutical formulations for sustained drug delivery Grant 6,699,833 - Gefter , et al. March 2, 2 | 2004-03-02 |
Pharmaceutical formulations for sustained drug delivery App 20030171296 - Gefter, Malcolm L. ;   et al. | 2003-09-11 |
Methods for treating FSH related conditions with GnRH antagonists App 20020058035 - Garnick, Marc B. ;   et al. | 2002-05-16 |
Methods for treating sex hormone-dependent conditions with Lhrh antagonists Grant 6,384,017 - Garnick , et al. May 7, 2 | 2002-05-07 |
Methods for treating LHRH associated disorders with LHRH antagonists Grant 6,211,153 - Garnick , et al. April 3, 2 | 2001-04-03 |
Pharmaceutical formulations for sustained drug delivery Grant 6,180,608 - Gefter , et al. January 30, 2 | 2001-01-30 |
Methods for treating LHRH associated disorders with LHRH antagonists Grant 6,180,609 - Garnick , et al. January 30, 2 | 2001-01-30 |
Pharmaceutical formulations for sustained drug delivery Grant 5,968,895 - Gefter , et al. October 19, 1 | 1999-10-19 |
Methods for treating prostate cancer with LHRH antagonists Grant 5,843,902 - Garnick , et al. December 1, 1 | 1998-12-01 |
Methods for treating prostate cancer with LHRH-R antagonists Grant 5,780,435 - Garnick , et al. July 14, 1 | 1998-07-14 |
Site specific synthesis of conjugated peptides Grant 5,428,128 - Mensi-Fattohi , et al. June 27, 1 | 1995-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.